Skip to main content

COVID-19 research by HFSP awardees and alumni

Since the discovery of SARS CoV-2 and the subsequent outbreak of the COVID-19 pandemic, HFSP alumni and awardees are actively contributing to advancing knowledge about the virus. Here are some examples of their research.

Human agents for developing scenarios to manage the COVID-19 pandemic

HFSP research grant alumnus Michael Meyer-Hermann is playing a central role in Germany's management of the COVID-19 pandemic.

Michael Meyer-Hermann in conversation with Guntram Bauer, HFSPO Director of Science Policy and Communications. The discussion centers around Michael's two HFSP grants and his recent work on modelling the COVID-19 pandemic.

A hidden source for T cell epitopes in the SARS-CoV-2 genome

A study by HFSP Long-Term Fellow Shira Weingarten-Gabbay and colleagues sheds light on an important yet overlooked source for T cell targets that can potentially increase COVID-19 vaccine efficacy. The team suggests that incorporating hidden T cell epitopes into future vaccines may improve T cell immunity. 

Lab-grown mini-lungs reveal SARS-CoV-2 infection in human alveoli

HFSP grantee Young Seok Ju developed miniature models of critical lung structures called alveoli, and used them to study how the coronavirus that causes COVID-19 infects the lungs in the laboratory.

A new meta-search tool identified SARS-CoV-2-like sequences in pangolin viromes

HFSP Long-Term Fellow Dae-Eun Jeong and colleagues developed a fast and extensive meta-search tool that led to the observation of SARS-CoV-2-homologous sequences in pangolin lung viromes.

The effects of COVID-19 on the brains of Covid long-haulers

HFSP alumna Fernanda de Felice is concerned that COVID-19 poses a risk to the brain and about the potential neurological consequences of infection. 

What we can learn about vertebrate ancestry, immunology and skeletal formation from sponges

A historic HFSP research grant awarded in 1996 for the project “Invertebrate molecular immunology: alloreactivity and putative immune genes” has been credited as one of the cornerstones of an impressive body of research that includes the development of a new protective barrier preventing COVID-19 virus attachment to human cells in the airway system.

 

Media contacts

Guntram Bauer
Director of Science Policy and Communications

Rosalyn Huie
Communications Officer

Click here to show mail address